Dr Marinos Kyriakopoulos

Dr Marinos Kyriakopoulos


Dr Marinos Kyriakopoulos

Consultant Child and Adolescent Psychiatrist of the National and Specialist Acorn Lodge Inpatient Children’s Unit of South London and Maudsley NHS Foundation Trust and Visiting Senior Lecturer in Child and Adolescent Psychiatry at the Institute of Psychiatry, Psychology and Neuroscience, King’s College London. He also holds an Adjunct Assistant Professor position at Icahn School of Medicine at Mount Sinai, New York, USA and an Honorary Consultant position at the Tourette Syndrome Clinic, Great Ormond Street Hospital for Children. He is Co-chair of the Neuroimaging Section of the European Psychiatric Association and member of the Executive Committee of the Child and Adolescent Psychiatry Surveillance System of the Royal College of Psychiatrists. He has a special interest in early-onset psychotic disorders, developmental neuropsychiatry and psychopharmacology, and inpatient psychiatric treatment in childhood and adolescence.

Dr Kyriakopoulos trained in clinical psychiatry, specialising in child and adolescent psychiatry, at St Mary’s, Maudsley and Great Ormond Street hospitals. He has received a number of awards including a NARSAD 2008 Young Investigator Award (USA) and the 2009 Margaret Davenport Prize (Royal College of Psychiatrists). He completed his PhD at the Institute of Psychiatry, Psychology and Neuroscience, King’s College London, in 2010. His research focuses on brain structure and function in early-onset psychotic disorders, the interface between autism spectrum disorders and early-onset psychosis, and the stigma of mental health treatment in childhood.

Dr Kyriakopoulos has published over 30 peer reviewed papers and book chapters and has presented in numerous national and international conferences.

Autism Spectrum Disorders and Psychosis


Autism spectrum disorders (ASD) and schizophrenia were separated into different diagnostic categories in the late 1970’s (DSM-III) having previously been considered as related diagnostic entities. Since then, several lines of evidence have indicated that these disorders show clinical and cognitive overlaps as well as some common neurobiological characteristics. Furthermore, there is a group of patients presenting with ASD and psychotic experiences who pose particular diagnostic and management challenges and may represent a subgroup of ASD more closely linked to psychosis. Evidence from a study of the first empirically derived classification of children with ASD in relation to psychosis based on three underlying symptom dimensions, anxiety, social deficits and thought disorder, will be presented. Further phenomenological, genetic and neuroimaging research on the clinical boundaries and overlapping pathophysiology of ASD and psychosis may help better define their relationship and lead to more effective interventions. Understanding this relationship will also provide a framework of working with patients with mixed clinical presentations.